The Paclitaxel In-Stent Controlled Elution Study (PISCES) is a nonrandomized, dose-ranging registry trial in patients with single de novo lesions that evaluated the Conor (Conor MedSystems, Inc., ...
Results from the PANDA III Study Reported at TCT 2015 SAN FRANCISCO – October 14, 2015 – Results from the multicenter, prospective, randomized PANDA III trial indicate that the BuMA sirolimus-eluting ...
SELUTION DeNovo is the largest DEB study ever initiated, involving up to 70 participating sites across 15 countries. Patients are randomized before any vessel preparation to reflect current medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback